SEC Form 4 research
| Issuer | Eikon Therapeutics, Inc. |
|---|---|
| Tickers | EIKN |
| Reporting owners | 32 |
| Officers and directors | 2 |
| Last public filing | 2026-09-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-03 | Column Group IV GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group Opportunity III GP, LP, Column Group Opportunity III, LP, Kutzkey Tim, Svennilson Peter, TCG Opportunity III GP, LLC | P | 89,200 | $11.56 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.